Acknowledgements The author thanks Morten Donsmark and Tine Bkdal (both Novo Nordisk A/S, Sborg, Denmark), and Kazushiro Fujiwara, and Eirik Quamme Bergan (both Novo Nordisk Pharma Ltd, Tokyo, Japan) for reviewing the manuscript, and to Andy Bond of Spirit Medical Communications Group Ltd for medical writing and editorial assistance (funded by Novo Nordisk A/S, Sborg, Denmark)
Under the NASA Nebraska Space Grant Student Fellowship at the University of NebraskaLincoln, in collaboration with Quantum Electro Dynamics, I am researching the Variable Electromagnetic (VEM) drive concept
However, it is not clear whether dosing reductions would be necessary in elderly patients, since these pharmacokinetic alterations may be offset by age-related differences in responsiveness of target organs and/or less pronounced suppression of adrenal release of cortisol
Remember how we discussed there were two ways normal valproic acid metabolism could ultimately interfere with the urea cycle